The antiandrogenic effect of finasteride against a mutant androgen receptor

Chemotherapeutic sensitization by endoplasmic reticulum stress: Increasing the efficacy of taxane against prostate cancer

(2010) Yue Wu et al.   CANCER BIOLOGY & THERAPY

Saturable Binding of Finasteride to Steroid 5α-reductase as Determinant of Nonlinear Pharmacokinetics

(2010) Rie Suzuki et al.   Drug Metabolism and Pharmacokinetics

Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways

(2009) André N. Vis et al.   BJU INTERNATIONAL

Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy

(2009) M. P. Steinkamp et al.   CANCER RESEARCH

Prx1 Enhances Androgen Receptor Function in Prostate Cancer Cells by Increasing Receptor Affinity to Dihydrotestosterone

(2009) R. R. Chhipa et al.   MOLECULAR CANCER RESEARCH

Androgen biosynthetic pathways in the human prostate

(2008) Van Luu-The et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Pleiotropic functional properties of androgen receptor mutants in prostate cancer

(2008) Jean-Pierre Bergerat et al.   HUMAN MUTATION

5α-Reductase inhibitor treatment of prostatic diseases: background and practical implications

(2008) J Dörsam et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Mechanisms mediating androgen receptor reactivation after castration

(2008) Xin Yuan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS